Alpha-Methylacyl-CoA Racemase Deficiency

Known as: AMACR, AMACR DEFICIENCY, AMACRD 
A rare disorder caused by mutation in the AMACR gene. It is characterized by neurological abnormalities that appear in adulthood and include… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
GOLPH2 is coding the 73-kDa type II Golgi membrane antigen GOLPH2/GP73. Upregulation of GOLPH2 mRNA has been recently reported in… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Alpha-methylacyl CoA racemase (AMACR) is overexpressed in prostate cancer relative to benign prostatic tissue. AMACR expression… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2005
2005
We assessed the usefulness of immunohistochemical analysis with a 3-antibody cocktail (alpha-methylacyl coenzyme A racemase… (More)
Is this relevant?
2004
2004
alpha-Methylacyl-CoA racemase (Amacr) deficiency in humans leads to sensory motor neuronal and liver abnormalities. The disorder… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
MOTIVATION To understand cancer etiology, it is important to explore molecular changes in cellular processes from normal state to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Alpha-methylacyl-CoA racemase (AMACR) was first discovered by using cDNA microarray technology as a molecular marker for prostate… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Although prostate-specific antigen (PSA) is a prototypic biomarker for prostate cancer, it has poor specificity… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
AIM To test whether alpha-methylacyl-CoA racemase (AMACR) is a sensitive and specific marker of prostate cancer. METHODS AND… (More)
Is this relevant?
Review
2004
Review
2004
The diagnosis of limited adenocarcinoma of the prostate is one of the more difficult challenges in surgical pathology. This paper… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 5
Is this relevant?